Enhancing muscle membrane repair by gene delivery of MG53 ameliorates muscular dystrophy and heart failure in Î´-Sarcoglycan-deficient hamsters.

He, Bo; Tang, Ru-hang; Weisleder, Noah; Xiao, Bin; Yuan, Zhenhua; Cai, Chuanxi; Zhu, Hua; Lin, Peihui; Qiao, Chunping; Li, Jianbin; Mayer, Christina; Li, Juan; Ma, Jianjie; Xiao, Xiao

He, Bo; Tang, Ru-hang; Weisleder, Noah; Xiao, Bin; Yuan, Zhenhua; Cai, Chuanxi; Zhu, Hua; Lin, Peihui; Qiao, Chunping; Li, Jianbin; Mayer, Christina; Li, Juan; Ma, Jianjie; Xiao, Xiao.

Affiliation

He B; Division of Molecular Pharmaceutics, University of North Carolina Eshelman School of Pharmacy, Chapel Hill, North Carolina, USA.

Mol Ther ; 20(4): 727-35, 2012 Apr.

Article in En | MEDLINE | ID: mdl-22314291

Subject(s)

Carrier Proteins/metabolism; Genetic Therapy/methods; Heart Failure/therapy; Muscular Dystrophies/therapy; Sarcoglycans/deficiency; Animals; Carrier Proteins/genetics; Caveolin 3/genetics; Caveolin 3/metabolism; Cricetinae; Dependovirus/genetics; Heart Failure/metabolism; Humans; Muscle Proteins/genetics; Muscle Proteins/metabolism; Muscular Dystrophies/metabolism; Tripartite Motif Proteins

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genetic Therapy / Carrier Proteins / Sarcoglycans / Heart Failure / Muscular Dystrophies Limits: Animals / Humans Language: En Journal: Mol Ther Journal subject: BIOLOGIA MOLECULAR / TERAPEUTICA Year: 2012 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google